<DOC>
	<DOCNO>NCT01998347</DOCNO>
	<brief_summary>There standard chemotherapy regimens metastatic esophageal cancer . Cisplatin plus 5-fluorouracil widely use first-line treatment response rate range 30 % 40 % . Combination paclitaxel cisplatin investigate small size clinical trial , produce promising outcome.Liposome capsule paclitaxel prove effective paclitaxel.The usefulness regimen paclitaxel liposome cisplatin evaluate median survival time , progression free survival , response rate .</brief_summary>
	<brief_title>Paclitaxel Liposome Cisplatin First-line Chemotherapy Patients With Metastatic Esophageal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>Histologically confirm metastatic esophageal tumor previous treatment advance disease recurrent disease previous treatment least one year . At least one measurable lesion accord RECIST1.1 ( Response Evaluation Criteria Solid Tumors RECIST Version 1.1 ) criterion . Minimum indicator lesion size : &gt; 10 mm measure spiral CT &gt; 20mm measure conventional technique . Patients age 18 70 year , inclusive , time acquisition inform consent Patients performance status ( ECOG ) 0 1 . Abnormal hematologic value ( WBC ≥ 3.0 x 109/L , Hemoglobin ≥ 10.0g/dl , platelet count ≥ 100 x 109/L ) Creatinine clearance ≥ 60 ml/min , Serum creatinine ≤ 1.5mg/dl Serum bilirubin ≤ 1.5mg/dl . ALT ( Alanine transaminase ) , AST ( Aspartate Transaminase ) ≤ 2.5 x upper normal limit ( ≤ 2.5 x upper normal limit case liver metastasis ) Life expectancy ≥ 3 month Patients give write informed consent participate study Patients active multiple cancer ; even multiple cancer metachronous , diseasefree period le 5 year ( exclude cancer situ skin cancer ) Serious , uncontrolled , concurrent infection ( ) illness ( es ) Patients serious concurrent complication ( heart disease , Intestinal pneumonia ) Patients brain metastasis Patients receive continuous administration steroid Patients experience serious drug allergy past Patients retention body fluid ( pleural effusion , ascites , pericardial effusion ) necessitate treatment Patients pregnant lactate hope become pregnant study period Patients prior Taxane treatment ( Paclitaxel ) Others , patient judge investigator coinvestigator inappropriate subject</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>